- GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
- Appendix 4C & Quarterly Business Update – March 2024
- Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
- Genetic Technologies Announces $2 Million Registered Direct Offering
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
- GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
- GTG to pilot GeneType in Breast Screen centers across the U.S.
- EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
- Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
- GTG Global Collaborations and Innovation Update
More ▼
Key statistics
On Friday, Genetic Technologies Ltd (GENE:NAQ) closed at 2.29, 27.22% above the 52 week low of 1.80 set on Feb 26, 2024.
52-week range
Open | 2.31 |
---|---|
High | 2.38 |
Low | 2.21 |
Bid | 2.22 |
Offer | 2.34 |
Previous close | 2.29 |
Average volume | 26.05k |
---|---|
Shares outstanding | 4.41m |
Free float | 3.97m |
P/E (TTM) | -- |
Market cap | 11.31m USD |
EPS (TTM) | -1.16 USD |
Data delayed at least 15 minutes, as of May 10 2024 20:59 BST.
More ▼